{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:16:56Z","timestamp":1760710616365,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"CAMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.vaccine.2021.05.058","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T23:18:57Z","timestamp":1622589537000},"page":"3952-3963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71"],"prefix":"10.1016","volume":"39","author":[{"given":"Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxiang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runxiang","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.05.058_b0005","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1016\/j.vaccine.2020.11.019","article-title":"Long-term seropositivity, safety, and impact of inactivated and live, attenuated hepatitis a vaccines in China - A cross-sectional study","volume":"38","author":"Xiaojin","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.058_b0010","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.vaccine.2018.01.043","article-title":"The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004\u20132016","volume":"36","author":"Sun","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.058_b0015","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.31429","article-title":"Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting System","volume":"73","author":"Wang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2021.05.058_b0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.05.058_b0025","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.05.058_b0030","doi-asserted-by":"crossref","DOI":"10.1542\/peds.109.6.e88","article-title":"Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease\/herpangina in children during an epidemic in Taiwan","volume":"109","author":"Chang","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.05.058_b0035","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.vaccine.2020.02.013","article-title":"Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial","volume":"38","author":"Xu","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.05.058_b0040","first-page":"1491","article-title":"A qualification of data analysis program TOXSTAT 2006 base on microsoft EXCEL","volume":"22","author":"Zhu","year":"2013","journal-title":"Chinese Journal of New Drugs."},{"key":"10.1016\/j.vaccine.2021.05.058_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.06.004","article-title":"Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study","author":"Ma","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2021.05.058_b0050","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/cid\/ciz1114","article-title":"Effectiveness and Safety of an Inactivated Enterovirus 71 Vaccine in Children Aged 6\u201371 Months in a Phase IV Study","volume":"71","author":"Guan","year":"2020","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America."},{"key":"10.1016\/j.vaccine.2021.05.058_b0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ijlh.13147","article-title":"Effects of hemolysis, bilirubin, and lipemia interference on coagulation tests detected by two analytical systems","volume":"42","author":"Nougier","year":"2020","journal-title":"International journal of laboratory hematology."},{"key":"10.1016\/j.vaccine.2021.05.058_b0060","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2018.030711","volume":"28","author":"Novelli","year":"2018","journal-title":"Biochemia medica."},{"key":"10.1016\/j.vaccine.2021.05.058_b0065","first-page":"151","article-title":"The etiology of hypertransaminasemia in Turkish children","volume":"16","author":"Serdaro\u011flu","year":"2016","journal-title":"Bosnian journal of basic medical sciences."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21006538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21006538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:57:23Z","timestamp":1759402643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21006538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":13,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0264410X21006538"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.058","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}